How Pfizer developed a COVID pill in record time
Pfizer researchers looking for a drug to treat SARS found clues that gave the company a head start in its quest for a pill to treat COVID-19, including the omicron variant.
antiviral
Experimental Medicines For COVID-19 Could Help Someday, But Home Runs Not Guaranteed
Drugs are being tested that could reduce symptoms and save lives. But, given the way drugs are developed, it's unlikely that any single medicine will be anywhere as potent as a successful vaccine.
Remdesivir Distribution Causes Confusion, Leaves Some Hospitals Empty-Handed
Gilead Sciences is donating its initial supply of the experimental treatment for COVID-19. The federal government is deciding where the scarce medicine goes, and there are questions about the choices.
Putting A Price On COVID-19 Treatment Remdesivir
Gilead Sciences has committed to donating the initial supply of the experimental antiviral drug. But executives said the company will need to make expanded production of the treatment sustainable.
Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed
On Friday, the Food and Drug Administration authorized emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.